ConductScience.org, home

Paper11325232

Schizanrins [corrected] B, C, D, and E, four new lignans from Kadsura matsudai and their antihepatitis activities.

Kuo YH and 5 others. J Nat Prod, 2001. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Schizanrins [corrected] B, C, D, and E, four new lignans from Kadsura matsudai and their antihepatitis activities. Papers, record 11325232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11325232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Schizanrins [corrected] B, C, D, and E, four new lignans from Kadsura matsudai and their antihepatitis activities.
PubMed
Journal
J Nat Prod
PubMed
Year
2001
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.05
iCite
Revised in PubMed
2019-09-06
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kuo YHY H
2Li SYS Y
3Huang RLR L
4Wu MDM D
5Huang HCH C
6Lee KHK H

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
HepatovirusMajor topic
LignansMajor topic
MagnoliopsidaMajor topic
Cell Line
HIV
Microbial Sensitivity Tests
Molecular Structure
Structure-Activity Relationship
Virus Replication

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
35564239Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2.Nanomaterials (Basel)2022https://conductscience.org/library/papers/35564239PubMed
35552885Lignans and sesquiterpenoids from the stems of Schisandra bicolor var. tuberculate.Nat Prod Bioprospect2022https://conductscience.org/library/papers/35552885PubMed
34202844A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.Molecules2021https://conductscience.org/library/papers/34202844PubMed
34093097Plant-derived lignans as potential antiviral agents: a systematic review.Phytochem Rev2022https://conductscience.org/library/papers/34093097PubMed
33234268Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents.Sci Total Environ2021https://conductscience.org/library/papers/33234268PubMed
24955298Panaxadiol and panaxatriol derivatives as anti-hepatitis B virus inhibitors.Nat Prod Bioprospect2014https://conductscience.org/library/papers/24955298PubMed
23429345Neglschisandrins E-F: two new lignans and related cytotoxic lignans from Schisandra neglecta.Molecules2013https://conductscience.org/library/papers/23429345PubMed
23322017Depigmentation effect of kadsuralignan F on melan-a murine melanocytes and human skin equivalents.Int J Mol Sci2013https://conductscience.org/library/papers/23322017PubMed
23153834Traditional Chinese herbal medicine as a source of molecules with antiviral activity.Antiviral Res2013https://conductscience.org/library/papers/23153834PubMed
21528904Ni-catalyzed ketene cycloaddition: a system that resists the formation of decarbonylation side products.J Am Chem Soc2011https://conductscience.org/library/papers/21528904PubMed
20811804The synergism of natural compounds in the pursuit of safe and healthier food.J Ind Microbiol Biotechnol2011https://conductscience.org/library/papers/20811804PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11325232

GET https://conductscience.org/api/papers/v1/11325232/authors